Department of Physiology, University of Lausanne, Lausanne, Switzerland.
Obes Rev. 2015 Feb;16 Suppl 1:55-66. doi: 10.1111/obr.12256.
Over the last two decades, several genes have been identified that appear to play a role in the regulation of energy homeostasis and body weight. For a small subset of them, a reduction or an absence of expression confers a resistance to the development of obesity. Recently, a knockin mouse for a member of the monocarboxylate transporter (MCT) family, MCT1, was demonstrated to exhibit a typical phenotype of resistance to diet-induced obesity and a protection from its associated metabolic perturbations. Such findings point out at MCTs as putatively new therapeutic targets in the context of obesity. Here, we will review what is known about MCTs and their possible metabolic roles in different organs and tissues. Based on the description of the phenotype of the MCT1 knockin mouse, we will also provide some insights about their putative roles in weight gain regulation.
在过去的二十年中,已经鉴定出一些基因,它们似乎在调节能量平衡和体重方面发挥作用。对于其中一小部分基因,其表达的减少或缺失赋予了对肥胖发展的抗性。最近,一种单羧酸转运体(MCT)家族成员 MCT1 的敲入小鼠表现出对饮食诱导肥胖的典型抗性表型,并对其相关代谢紊乱具有保护作用。这些发现指出 MCT 可能是肥胖症治疗的新潜在靶点。在这里,我们将回顾关于 MCT 及其在不同器官和组织中的可能代谢作用的已知内容。基于对 MCT1 敲入小鼠表型的描述,我们还将提供一些关于它们在体重调节中的潜在作用的见解。